Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300072925Phase 4Not yet recruiting
Phase 4, randomised trial of esketamine in lower limb orthopedic disorders (2 arms), sponsored by Fuyang Hospital of Anhui Medical University. Primary endpoint: Incidence of intraoperative tourniquet hypertension. Planned start Jul 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300072925.